Novartis Clinical Trials and Medical Research Studies Recruiting in the U.S.

Mailing List


	Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only.

Novartis Clinical Trials provides information about research studies recruiting within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S.

Clinical Trial and Medical Research Information

For Patients and Caregivers

Clinical trials are scientific and medical research studies designed to find better ways to treat or prevent diseases. The Novartis clinical trials website is designed to inform the public about important medical research studies as well as to educate patients and caregivers about the clinical trial process. To find out more about Novartis clinical trials currently enrolling in the U.S., please select a health condition below. Novartis recommends you consult with your physician before participating in a clinical trial.

Search for Clinical Trials by Health Condition

	Acute Myelogenous Leukemia (AML)
	Alzheimer's Disease
	Breast Cancer
	Carcinoid Tumors
	Chronic Heart Failure
	Chronic Myelogenous Leukemia (CML)
	Chronic Obstructive Pulmonary Disease (COPD)
	Dementia
	Depression
	Diffuse Large B-Cell Lymphoma
	Eczema/Dermatitis
	Endometriosis
	Gastric Cancer
	Gastrointestinal Stromal Tumor (GIST)
	Gout
	High Blood Pressure
	Hodgkins Lymphoma
	Juvenile Arthritis

	Kidney Cancer (clear cell carcinoma)
	Kidney Cancer (renal cell cancer)
	Kidney Transplantation
	Liver Cancer
	Lung Cancer
	Lymphoma
	Mantle Cell Lymphoma
	Metastatic Melanoma
	Multiple Myeloma
	Multiple Sclerosis (MS)
	Myelofibrosis
	Neurogenic Bladder
	Oncology
	Overactive Bladder
	Paget's Disease of Bone
	Pulmonary Hypertension
	Tuberous Sclerosis
	Uveitis

Featured Novartis Clinical Trials

Malignant Melanoma Study - US255

Novartis Oncology is supporting a clinical study that is being sponsored and conducted by Dr. F. Stephen Hodi of the Dana-Farber Cancer Institute, to find out if a Novartis study drug is safe and effective for people with metastatic acral lentiginous melanoma. An "investigational drug" is a drug that is being clinically tested and is not approved for sale or use in the United States by the Food and Drug Administration (FDA), for the indication in which it is being studied.

Chronic Myelogenous Leukemia (CML) Study - AUS09

A multi-center, open-label, exploratory research study for people suffering with CML in the chronic phase (CML-CP), who achieved a complete cytogenetic response (CCyR) while on an established therapy, but have a suboptimal molecular response.

Pulmonary Hypertension Study A2301

The purpose of this clinical trial is to determine the benefits and safety of a Novartis investigative drug as an add-on therapy in the treatment of people with severe pulmonary arterial hypertension. An "investigational drug" is a drug that is being clinically tested and is not approved for sale or use in the United States by the Food and Drug Administration (FDA), for the indication in which it is being studied.

Juvenile Idiopathic Arthritis (SJIA) Studies - G2301/G2305

Two studies are currently available for participation, the doctor will help you determine which study is right for you. The purpose of these two studies is to assess the initial and sustained efficacy and safety of a Novartis investigational drug in participants with SJIA having a flare. Both studies contain randomized, double-bind, placebo controlled parts but all subjects will receive the investigational drug at some point. An "investigational drug" is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA)." An "investigational drug" is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA).

Liver Cancer Study CRAD001O2301 - DNU

The purpose of this study is to measure the safety and effectiveness of a Novartis investigational drug in patients with advanced liver cancer. This study drug is an investigational drug, which means it is being tested and is not approved for the treatment of people with liver cancer in the United States by the U.S. Food and Drug Administration (FDA).

Endometriosis Study - A2202

The purpose of this double blind, randomized, controlled, multicenter study is to measure effectiveness and verify the safety and tolerability of a Novartis investigational drug in reducing pelvic pain when given together with an oral contraceptive (birth control pill) in women that are suffering from refractory endometriosis. An "investigational drug" is a drug that is being clinically tested and is not approved for sale or use in the United States by the Food and Drug Administration (FDA), for the indication in which it is being studied.

Major Depressive Disorder Study - C2301

The purpose of this 8-week, randomized, double-blind, placebo-controlled, parallel-group, multi-center study is to assess the efficacy, safety, and tolerability of an investigational drug administered once daily in patients with Major Depressive Disorder (MDD). An "investigational drug" is a drug that is being clinically tested and is not approved for sale or use in the United States by the Food and Drug Administration (FDA), for the indication in which it is being studied.

Major Depressive Disorder Study - C2302

The purpose of this 8-week, randomized, double-blind, placebo-controlled, parallel-group, multi-center study is to evaluate the efficacy and safety of an investigational drug administered once daily in patients with Major Depressive Disorder (MDD). An "investigational drug" is a drug that is being clinically tested and is not approved for sale or use in the United States by the Food and Drug Administration (FDA), for the indication in which it is being studied.

Multiple Sclerosis (Primary Progressive) Study - D2306

The main purpose of this study is to evaluate how effective a Novartis investigational drug is in delaying disability progression in patients with primary progressive multiple sclerosis. It will also evaluate how safe and well tolerated the investigational drug is in patients with primary progressive multiple sclerosis.

Additional Clinical Trial Information for Patients and Caregivers

ClinicalTrials.gov is a registry of federally and privately supported clinical trial and medical research studies conducted globally. The U.S. National Institutes of Health (NIH), through its National Library of Medicine (NLM), has developed this site in collaboration with the Food and Drug Administration (FDA), as a result of the FDA Modernization Act, passed into law in November 1997.

ClinicalTrials.gov provides the public with up-to-date information on clinical research. Each clinical trial listing will provide information about the trial's purpose, participation eligibility, and contact information.

	Site Map \| Contact Us \| Find a Clinical Trial \| Mailing List \| Clinical Trial FAQs
	Clinical Trials Glossary \| About Informed Consent \| Medical Research Areas
	Clinical Trial Resources \| How to use this website